Funding for this research was provided by:
National Natural Science Foundation of China (81572039)
Shanghai Science and Technology Commission (16411961300, 17DZ2293300, YDZX20193100002868)
Clinical Research Plan of SHDC (16CR3111B, 16CR1029B)
National megaproject on key infectious diseases (2017ZX10202102-001-007)
Received: 18 October 2021
Accepted: 25 May 2022
First Online: 4 June 2022
: This study was approved by the ethical review committee of Shanghai Skin Disease Hospital (Shanghai, China; approval number: 2022-07).
: Not applicable.
: The authors declare that they have no conflict of interests.